How much does a CEO of Encompass Health make?

Written by Editorial Team | Last Updated: August 2026

The Chief Executive Officer of Encompass Health receives an executive remuneration package totaling several millions of dollars annually, combining a competitive fixed base salary with performance-linked cash bonuses, restricted stock units, and long-term equity incentives. These compensation structures are reviewed by the board of directors' compensation committee to ensure alignment with industry benchmarks, operational growth milestones, and long-term shareholder value creation.

Related FAQs

Corporate legal matters and historical litigation involving Encompass Health (and its predecessor entity HealthSouth) have occasionally involved regulatory compliance reviews, billing practice inquiries, or standard commercial disputes typical of lar...

Encompass Health stands out among post-acute healthcare peers as the undisputed market leader in inpatient rehabilitation, boasting superior scale with over 175 specialized hospitals, high occupancy efficiency, and strong clinical quality metrics rec...

Health Advocate, a prominent provider of health advocacy, employee assistance programs, and healthcare navigation services, competes against various specialized corporate wellness and navigation firms.

Encompass Health specializes in providing high-acuity inpatient rehabilitation hospital care, representing a distinct level of post-acute medical treatment designed for patients recovering from severe strokes, neurological conditions, brain injuries,...

Encompass Health Corporation (EHC) operates as a premier provider of inpatient rehabilitation healthcare services in the United States, competing against other major inpatient rehabilitation facility operators, specialized post-acute care networks, a...

Wall Street equity research analysts tracking Encompass Health Corporation maintain an average 12-month consensus price target reflecting positive sentiment regarding its dominant post-acute care positioning.

Determining whether Encompass Health (NYSE: EHC) represents a favorable investment depends on individual risk tolerance, portfolio strategy, and outlook on the healthcare sector.

Encompass Health operates with a dedicated national workforce comprising tens of thousands of skilled healthcare professionals.

Periodic downward price adjustments or valuation pullbacks for Encompass Health stock are typically driven by broader macroeconomic market corrections, shifting healthcare policy discussions, labor cost pressures, or changes in Medicare reimbursement...

Employee evaluations regarding Encompass Health generally highlight a rewarding professional environment focused on patient recovery, comprehensive clinical training programs, and solid healthcare benefits.

Medicare may deny coverage for inpatient rehabilitation facility (IRF) care if the patient's medical documentation fails to satisfy strict coverage criteria, such as proving the necessity of intensive, multidisciplinary therapy requiring at least thr...

Executive compensation packages for major American healthcare, pharmaceutical, and hospital management corporations frequently rank among the highest in corporate America, with top CEOs commanding multi-million-dollar annual packages comprising base ...

The Chief Executive Officer of Encompass Health receives an annual executive compensation package totaling several millions of dollars, combining a competitive fixed base salary with performance-based cash incentives, restricted stock units, and long...

Encompass Health Corporation is a publicly traded corporation listed on the New York Stock Exchange under the ticker symbol EHC, meaning it is owned collectively by public shareholders, institutional asset management firms, mutual funds, and index pr...

Encompass Health Corporation was formerly known as HealthSouth Corporation, which grew to become one of the largest providers of rehabilitative healthcare services in the United States.

Mark Tarr, serving as the President and Chief Executive Officer of Encompass Health Corporation, receives a comprehensive executive compensation package structured in accordance with corporate governance guidelines.

Encompass Health is guided by an experienced executive leadership team spearheaded by Mark J. Tarr, who serves as the President and Chief Executive Officer, directing corporate strategy and operational execution.

Medicare and federal healthcare guidelines utilize specific diagnostic criteria for inpatient rehabilitation facility (IRF) admissions, focusing on conditions that require intensive, multidisciplinary rehabilitative therapy.

EHC serves as the official stock exchange ticker symbol for Encompass Health Corporation on the New York Stock Exchange, representing publicly traded common equity ownership in the premier post-acute healthcare services provider.

Encompass Health utilizes specialized electronic health record (EHR) systems designed specifically to manage complex post-acute inpatient rehabilitation workflows, clinical documentation, and multidisciplinary therapy tracking.

Encompass Health Corporation was formerly known globally as HealthSouth Corporation, one of the largest providers of inpatient rehabilitative healthcare services in the United States.

The 60% rule is a federal regulatory compliance standard established by the Centers for Medicare & Medicaid Services for inpatient rehabilitation facilities in the United States.

Encompass Health Corporation (EHC) exhibits strong growth prospects driven by favorable demographic trends, particularly the rapid aging of the American population and the rising demand for specialized inpatient rehabilitative care.

Encompass Health Corporation (originally founded under the name HealthSouth Corporation) was established in 1984 by Richard M. Scrushy along with a group of healthcare partners in Birmingham, Alabama.

Encompass Health is not ranked within the top tier of the Fortune 100 list, though its multi-billion-dollar annual revenues position it comfortably within broader corporate rankings, including components of indices like the S&P MidCap 400.